Biased signaling pathways via CXCR3 control the development and function of CD4+ T cell subsets

Journal of Leukocyte Biology

Volumn 99, Issue 6, 2016, Pages 857-862

  Karin, Nathan ^a   Wildbaum, Gizi ^a   Thelen, Marcus ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

Chemokines; CXCL12; Immunotherapy; Regulatory T cells; Tolerance

Indexed keywords

CCL25 CHEMOKINE; CD4 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; BIOLOGICAL FACTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CELL POLARITY; DISEASE EXACERBATION; EFFECTOR CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE; ANIMAL; DRUG EFFECTS; LYMPHOCYTE SUBPOPULATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL FACTORS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INFLAMMATION; LYMPHOCYTE SUBSETS; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION;

EID: 84971373567     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.2MR0915-441R     Document Type: Review

References (103)

1. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
2. Proudfoot, A. E. (2002) Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2, 106-115.
3. Luster, A. D. (1998) Chemokines—chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338, 436-445.
4. Stoolman, L. M. (1989) Adhesion molecules controlling lymphocyte migration. Cell 56, 907-910.
5. Elices, M. J., Osborn, L., Takada, Y., Crouse, C., Luhowskyj, S., Hemler, M. E., Lobb, R. R. (1990) VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60, 577-584.
6. Osborn, L. (1990) Leukocyte adhesion to endothelium in inflammation. Cell 62, 3-6.
7. Springer, T. A. (1990) Adhesion receptors of the immune system. Nature 346, 425-434.
8. Spertini, O., Kansas, G. S., Munro, J. M., Griffin, J. D., Tedder, T. F. (1991) Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin. Nature 349, 691-694.
9. Martinelli, R., Sabroe, I., LaRosa, G., Williams, T. J., Pease, J. E. (2001) The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J. Biol. Chem. 276, 42957-42964.
10. Sapir, Y., Vitenshtein, A., Barsheshet, Y., Zohar, Y., Wildbaum, G., Karin, N. (2010) A fusion protein encoding the second extracellular domain of CCR5 arrests chemokine-induced cosignaling and effectively suppresses ongoing experimental autoimmune encephalomyelitis. J. Immunol. 185, 2589-2599.
11. Izhak, L., Wildbaum, G., Zohar, Y., Anunu, R., Klapper, L., Elkeles, A., Seagal, J., Yefenof, E., Ayalon-Soffer, M., Karin, N. (2009) A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2. J. Immunol. 183, 732-739.
12. Wildbaum, G., Netzer, N., Karin, N. (2002) Plasmid DNA encoding IFNgamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J. Immunol. 168, 5885-5892.
13. Salomon, I., Netzer, N., Wildbaum, G., Schif-Zuck, S., Maor, G., Karin, N. (2002) Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J. Immunol. 169, 2685-2693.
14. Youssef, S., Maor, G., Wildbaum, G., Grabie, N., Gour-Lavie, A., Karin, N. (2000) C-C Chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. J. Clin. Invest. 106, 361-371.
15. Youssef, S., Wildbaum, G., Karin, N. (1999) Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines. J. Autoimmun. 13, 21-29.
16. Serbina, N. V., Pamer, E. G. (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311-317.
17. Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., Luster, A. D. (2000) Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J. Exp. Med. 192, 1075-1080.
18. Karpus, W. J., Kennedy, K. J., Kunkel, S. L., Lukacs, N. W. (1998) Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 187, 733-741.
19. Charo, I. F., Ransohoff, R. M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621.
20. Schall, T. J., Proudfoot, A. E. (2011) Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat. Rev. Immunol. 11, 355-363.
21. Zohar, Y., Wildbaum, G., Novak, R., Salzman, A. L., Thelen, M., Alon, R., Barsheshet, Y., Karp, C. L., Karin, N. (2014) CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. J. Clin. Invest. 124, 2009-2022.
22. Corbisier, J., Galès, C., Huszagh, A., Parmentier, M., Springael, J. Y. (2015) Biased signaling at chemokine receptors. J. Biol. Chem. 290, 9542-9554.
23. Steen, A., Larsen, O., Thiele, S., Rosenkilde, M. M. (2014) Biased and G protein-independent signaling of chemokine receptors. Front. Immunol. 5, 277.
24. Steen, A., Thiele, S., Guo, D., Hansen, L. S., Frimurer, T. M., Rosenkilde, M. M. (2013) Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7. J. Biol. Chem. 288, 12511-12521.
25. Zimmerman, B., Beautrait, A., Aguila, B., Charles, R., Escher, E., Claing, A., Bouvier, M., Laporte, S. A. (2012) Differential b-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs. Sci. Signal. 5, ra33.
26. Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., Wüthrich, K. (2012) Biased signaling pathways in b2-adrenergic receptor characterized by 19F-NMR. Science 335, 1106-1110.
27. Bardi, G., Lipp, M., Baggiolini, M., Loetscher, P. (2001) The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC. Eur. J. Immunol. 31, 3291-3297.
28. Nandagopal, S., Wu, D., Lin, F. (2011) Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields. PLoS One 6, e18183.
29. Ricart, B. G., John, B., Lee, D., Hunter, C. A., Hammer, D. A. (2011) Dendritic cells distinguish individual chemokine signals through CCR7 and CXCR4. J. Immunol. 186, 53-61.
30. Feniger-Barish, R., Ran, M., Zaslaver, A., Ben-Baruch, A. (1999) Differential modes of regulation of CXC chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine 11, 996-1009.
31. Jones, S. A., Wolf, M., Qin, S., Mackay, C. R., Baggiolini, M. (1996) Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc. Natl. Acad. Sci. USA 93, 6682-6686.
32. Ogilvie, P., Thelen, S., Moepps, B., Gierschik, P., da Silva Campos, A. C., Baggiolini, M., Thelen, M. (2004) Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway. J. Immunol. 172, 6715-6722.
33. Sauty, A., Colvin, R. A., Wagner, L., Rochat, S., Spertini, F., Luster, A. D. (2001) CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11). J. Immunol. 167, 7084-7093.
34. Colvin, R. A., Campanella, G. S., Sun, J., Luster, A. D. (2004) Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J. Biol. Chem. 279, 30219-30227.
35. Colvin, R. A., Campanella, G. S., Manice, L. A., Luster, A. D. (2006) CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol. Cell. Biol. 26, 5838-5849.
36. Cox, M. A., Jenh, C. H., Gonsiorek, W., Fine, J., Narula, S. K., Zavodny, P. J., Hipkin, R. W. (2001) Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol. Pharmacol. 59, 707-715.
37. Thompson, B. D., Jin, Y., Wu, K. H., Colvin, R. A., Luster, A. D., Birnbaumer, L., Wu, M. X. (2007) Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling. J. Biol. Chem. 282, 9547-9555.
38. Meiron, M., Zohar, Y., Anunu, R., Wildbaum, G., Karin, N. (2008) CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J. Exp. Med. 205, 2643-2655.
39. Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., Lefkowitz, R. J. (2010) Beta-arrestin- but not G proteinmediated signaling by the “decoy” receptor CXCR7. Proc. Natl. Acad. Sci. USA 107, 628-632.
40. Boldajipour, B., Mahabaleshwar, H., Kardash, E., Reichman-Fried, M., Blaser, H., Minina, S., Wilson, D., Xu, Q., Raz, E. (2008) Control of chemokine-guided cell migration by ligand sequestration. Cell 132, 463-473.
41. Dambly-Chaudière, C., Cubedo, N., Ghysen, A. (2007) Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev. Biol. 7, 23.
42. Donà, E., Barry, J. D., Valentin, G., Quirin, C., Khmelinskii, A., Kunze, A., Durdu, S., Newton, L. R., Fernandez-Minan, A., Huber, W., Knop, M., Gilmour, D. (2013) Directional tissue migration through a selfgenerated chemokine gradient. Nature 503, 285-289.
43. Venkiteswaran, G., Lewellis, S. W., Wang, J., Reynolds, E., Nicholson, C., Knaut, H. (2013) Generation and dynamics of an endogenous, selfgenerated signaling gradient across a migrating tissue. Cell 155, 674-687.
44. Abe, P., Mueller, W., Schütz, D., MacKay, F., Thelen, M., Zhang, P., Stumm, R. (2014) CXCR7 prevents excessive CXCL12-mediated downregulation of CXCR4 in migrating cortical interneurons. Development 141, 1857-1863.
45. Sánchez-Alcañiz, J. A., Haege, S., Mueller, W., Pla, R., Mackay, F., Schulz, S., López-Bendito, G., Stumm, R., Marìn, O. (2011) CXCR7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69, 77-90.
46. Humpert, M. L., Pinto, D., Jarrossay, D., Thelen, M. (2014) CXCR7 influences the migration of B cells during maturation. Eur. J. Immunol. 44, 694-705.
47. Cruz-Orengo, L., Holman, D. W., Dorsey, D., Zhou, L., Zhang, P., Wright, M., McCandless, E. E., Patel, J. R., Luker, G. D., Littman, D. R., Russell, J. H., Klein, R. S. (2011) CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208, 327-339.
48. Cantor, J., Haskins, K. (2007) Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. J. Immunol. 179, 5760-5767.
49. Martinez, F. O., Sica, A., Mantovani, A., Locati, M. (2008) Macrophage activation and polarization. Front. Biosci. 13, 453-461.
50. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., Coffman, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
51. Cua, D. J., Stohlman, S. A. (1997) In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. J. Immunol. 159, 5834-5840.
52. Liew, F. Y. (2002) T(H)1 and T(H)2 cells: a historical perspective. Nat. Rev. Immunol. 2, 55-60.
53. Wildbaum, G., Youssef, S., Grabie, N., Karin, N. (1998) Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. J. Immunol. 161, 6368-6374.
54. Schif-Zuck, S., Westermann, J., Netzer, N., Zohar, Y., Meiron, M., Wildbaum, G., Karin, N. (2005) Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells. J. Immunol. 174, 4307-4315.
55. Leonard, J. P., Waldburger, K. E., Goldman, S. J. (1995) Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181, 381-386.
56. Kang, B. Y., Kim, T. S. (2006) Targeting cytokines of the interleukin-12 family in autoimmunity. Curr. Med. Chem. 13, 1149-1156.
57. Butler, D. M., Malfait, A. M., Maini, R. N., Brennan, F. M., Feldmann, M. (1999) Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis. Eur. J. Immunol. 29, 2205-2212.
58. Sivakumar, P. V., Westrich, G. M., Kanaly, S., Garka, K., Born, T. L., Derry, J. M., Viney, J. L. (2002) Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50, 812-820.
59. Healey, D., Ozegbe, P., Arden, S., Chandler, P., Hutton, J., Cooke, A. (1995) In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95, 2979-2985.
60. Tian, J., Lehmann, P. V., Kaufman, D. L. (1997) Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186, 2039-2043.
61. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., Weaver, C. T. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132.
62. Kuestner, R. E., Taft, D. W., Haran, A., Brandt, C. S., Brender, T., Lum, K., Harder, B., Okada, S., Ostrander, C. D., Kreindler, J. L., Aujla, S. J., Reardon, B., Moore, M., Shea, P., Schreckhise, R., Bukowski, T. R., Presnell, S., Guerra-Lewis, P., Parrish-Novak, J., Ellsworth, J. L., Jaspers, S., Lewis, K. E., Appleby, M., Kolls, J. K., Rixon, M., West, J. W., Gao, Z., Levin, S. D. (2007) Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 179, 5462-5473.
63. Matsuzaki, G., Umemura, M. (2007) Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 51, 1139-1147.
64. Ma, C. S., Chew, G. Y., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., Cook, M. C. (2008) Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205, 1551-1557.
65. Wildbaum, G., Shahar, E., Katz, R., Karin, N., Etzioni, A., Pollack, S. (2013) Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion. J. Allergy Clin. Immunol. 132, 761-764.
66. Liu, L., Okada, S., Kong, X. F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J., Itan, Y., Audry, M., Nitschke, P., Masson, C., Toth, B., Flatot, J., Migaud, M., Chrabieh, M., Kochetkov, T., Bolze, A., Borghesi, A., Toulon, A., Hiller, J., Eyerich, S., Eyerich, K., Gulácsy, V., Chernyshova, L., Chernyshov, V., Bondarenko, A., Grimaldo, R. M., Blancas-Galicia, L., Beas, I. M., Roesler, J., Magdorf, K., Engelhard, D., Thumerelle, C., Burgel, P. R., Hoernes, M., Drexel, B., Seger, R., Kusuma, T., Jansson, A. F., Sawalle-Belohradsky, J., Belohradsky, B., Jouanguy, E., Bustamante, J., Bué, M., Karin, N., Wildbaum, G., Bodemer, C., Lortholary, O., Fischer, A., Blanche, S., Al-Muhsen, S., Reichenbach, J., Kobayashi, M., Rosales, F. E., Lozano, C. T., Kilic, S. S., Oleastro, M., Etzioni, A., Traidl-Hoffmann, C., Renner, E. D., Abel, L., Picard, C., Maródi, L., Boisson-Dupuis, S., Puel, A., Casanova, J. L. (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocuta eous candidiasis. J. Exp. Med. 208, 1635-1648.
67. Bird, L. (2012) Mucosal immunology: IL-22 keeps commensals in their place. Nat. Rev. Immunol. 12, 550-551.
68. Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K., Tian, Q., Watowich, S. S., Jetten, A. M., Dong, C. (2007) Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483.
69. Bettelli, E., Korn, T., Oukka, M., Kuchroo, V. K. (2008) Induction and effector functions of T(H)17 cells. Nature 453, 1051-1057.
70. Malgarini, R. B., Pimpinella, G. (2012) Briakinumab versus methotrexate for psoriasis. N. Engl. J. Med. 366, 379, author reply 380.
71. Papp, K. A., Leonardi, C., Menter, A., Ortonne, J. P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H., Baumgartner, S. (2012) Brodalumab, an anti-interleukin -17-receptor antibody for psoriasis. N. Engl. J. Med. 366, 1181-1189.
72. Waisman, A. (2012) To be 17 again—anti-interleukin-17 treatment for psoriasis. N. Engl. J. Med. 366, 1251-1252.
73. Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., Roncarolo, M. G. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742.
74. Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., Nomura, T. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8-27.
75. Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
76. Wing, K., Sakaguchi, S. (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13.
77. Shevach, E. M. (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645.
78. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G., Wahl, S. M. (2003) Conversion of peripheral CD4+CD252 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886.
79. Awasthi, A., Carrier, Y., Peron, J. P., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., Weiner, H. L. (2007) A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells. Nat. Immunol. 8, 1380-1389.
80. Apetoh, L., Quintana, F. J., Pot, C., Joller, N., Xiao, S., Kumar, D., Burns, E. J., Sherr, D. H., Weiner, H. L., Kuchroo, V. K. (2010) The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861.
81. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A., Weiner, H. L. (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240.
82. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., Karin, N. (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356, 63-66.
83. Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., O’Connor, P. W.; International Natalizumab Multiple Sclerosis Trial Group. (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348, 15-23.
84. Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M. M., Nagler, A., Lider, O., Alon, R., Zipori, D., Lapidot, T. (2000) The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95, 3289-3296.
85. Karin, N. (2010) The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J. Leukoc. Biol. 88, 463-473.
86. Shachar, I., Karin, N. (2013) The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J. Leukoc. Biol. 93, 51-61.
87. Frigerio, S., Junt, T., Lu, B., Gerard, C., Zumsteg, U., Holländer, G. A., Piali, L. (2002) Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 8, 1414-1420.
88. Liu, L., Huang, D., Matsui, M., He, T. T., Hu, T., Demartino, J., Lu, B., Gerard, C., Ransohoff, R. M. (2006) Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR32/2 mice with experimental autoimmune encephalomyelitis. J. Immunol. 176, 4399-4409.
89. Blättermann, S., Peters, L., Ottersbach, P. A., Bock, A., Konya, V., Weaver, C. D., Gonzalez, A., Schröder, R., Tyagi, R., Luschnig, P., Gäb, J., Hennen, S., Ulven, T., Pardo, L., Mohr, K., Gütschow, M., Heinemann, A., Kostenis, E. (2012) A biased ligand for OXE-R uncouples Ga and Gbg signaling within a heterotrimer. Nat. Chem. Biol. 8, 631-638.
90. Reiter, E., Ahn, S., Shukla, A. K., Lefkowitz, R. J. (2012) Molecular mechanism of b-arrestin-biased agonism at seven-transmembrane receptors. Annu. Rev. Pharmacol. Toxicol. 52, 179-197.
91. Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D. K., Caron, M. G., Lefkowitz, R. J. (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661.
92. Samama, P., Cotecchia, S., Costa, T., Lefkowitz, R. J. (1993) A mutationinduced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268, 4625-4636.
93. Sierro, F., Biben, C., Martìnez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., Harvey, R. P., Martìnez A C., Mackay, C. R., Mackay, F. (2007) Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104, 14759-14764.
94. Ephrem, A., Chamat, S., Miquel, C., Fisson, S., Mouthon, L., Caligiuri, G., Delignat, S., Elluru, S., Bayry, J., Lacroix-Desmazes, S., Cohen, J. L., Salomon, B. L., Kazatchkine, M. D., Kaveri, S. V., Misra, N. (2008) Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 111, 715-722.
95. Godfrey, W. R., Ge, Y. G., Spoden, D. J., Levine, B. L., June, C. H., Blazar, B. R., Porter, S. B. (2004) In vitro-expanded human CD4(+) CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104, 453-461.
96. Gregori, S., Bacchetta, R., Passerini, L., Levings, M. K., Roncarolo, M. G. (2007) Isolation, expansion, and characterization of human natural and adaptive regulatory T cells. Methods Mol. Biol. 380, 83-105.
97. Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., Hauben, E., Roncarolo, M. G. (2010) Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10- dependent ILT4/HLA-G pathway. Blood 116, 935-944.
98. Gagliani, N., Gregori, S., Jofra, T., Valle, A., Stabilini, A., Rothstein, D. M., Atkinson, M., Roncarolo, M. G., Battaglia, M. (2011) Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One 6, e28434.
99. Gregori, S., Roncarolo, M. G., Bacchetta, R. (2011) Methods for in vitro generation of human type 1 regulatory T cells. Methods Mol. Biol. 677, 31-46.
100. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., Roncarolo, M. G. (2001) IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166, 5530-5539.
101. Koreth, J., Matsuoka, K., Kim, H. T., McDonough, S. M., Bindra, B., Alyea E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., Bienfang, D. C., Prasad, S., Tzachanis, D., Joyce, R. M., Avigan, D. E., Antin, J. H., Ritz, J., Soiffer, R. J. (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365, 2055-2066.
102. Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., Klatzmann, D. (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N. Engl. J. Med. 365, 2067-2077.
103. Bluestone, J. A. (2011) The yin and yang of interleukin-2-mediated immunotherapy. N. Engl. J. Med. 365, 2129-2131.